Radhika Mathur, PhD

Title(s)Assistant Researcher, Neurological Surgery
SchoolSchool of Medicine
Address35 Medical Center Way, #422
San Francisco CA 94143
Phone415-514-1183
PronounsShe/Her/Hers
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    Harvard University, Cambridge, MAPh.D.05/2017Biological and Biomedical Sciences
    University of California, Berkeley, Berkeley, CABA05/2012Molecular and Cell Biology, Economics
    White House Office Of Science and Technology Policy, Washington, DCInternship12/2016Science Policy
    Collapse awards and honors
    Society for Neuro-Oncology (SNO)  - 2020Andrew Parsa Young Investigator Award for Basic/Translational Research
    National Institutes of Health (NIH), National Cancer Institute (NCI)2015  - 2017Ruth L. Kirschstein National Research Service Award (F31)
    Dana-Farber Cancer Institute  - 2015Best Poster Award, Annual Postdoc and Graduate Student Retreat
    Harvard Program In Therapeutics Science  - 2015Best Poster Award, Spring Symposium
    UC Berkeley  - 2012Honors, Molecular and Cell Biology
    UC Berkeley  - 2012High Honors, Economics
    UC Berkeley  - 2012Distinction in General Scholarship

    Collapse Research 
    Collapse research activities and funding
    Three-dimensional characterization of epigenomic intratumoral heterogeneity in IDH-mutant glioma
    NIH F32CA239472Jun 1, 2019 - Dec 31, 2021
    Role: Principal Investigator
    Investigating the role of ARID1A inactivation in colon cancer pathogenesis
    NIH F31CA199994Aug 1, 2015 - Jul 31, 2018
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Spatial 3D genome organization reveals intratumor heterogeneity in primary glioblastoma samples. Sci Adv. 2025 Mar 14; 11(11):eadn2830. Wang Q, Wang J, Mathur R, Youngblood MW, Jin Q, Hou Y, Stasiak LA, Luan Y, Zhao H, Hilz S, Hong C, Chang SM, Lupo JM, Phillips JJ, Costello JF, Yue F. PMID: 40073147; PMCID: PMC11900876.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    2. Overcoming heterogeneity with 3D whole-tumour sampling. Nat Rev Cancer. 2024 Dec; 24(12):825. Mathur R. PMID: 39251837.
      View in: PubMed   Mentions:    Fields:    
    3. IMMU-59. AN IMMUNOSUPPRESSIVE PROGRAM ENCOMPASSING MULTIPLE IMMUNE CELL TYPES IN GBM TYPIFIED BY NOVEL MARKER LRRC25 ASSOCIATED WITH TYROBP SIGNALING. Neuro-Oncology. 2024 Nov 11; 26(Supplement_8):viii165-viii166. Zamler ZD, Mathur MR, Chan CG, Schupp SP, Shai SA, Okada OH, Oldham OM, Costello CJ. .
      View in: Publisher Site   Mentions:
    4. Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression. Neuro Oncol. 2024 04 05; 26(4):640-652. Appin CL, Hong C, Suwala AK, Hilz S, Mathur R, Solomon DA, Smirnov IV, Stevers NO, Shai A, Wang A, Berger MS, Chang SM, Phillips JJ, Costello JF. PMID: 38141254; PMCID: PMC10995505.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    5. Abstract 5676: Spatial 3D genome organization reveals intratumor heterogeneity in primary glioblastoma samples. Cancer Research. 2024 Mar 22; 84(6_Supplement):5676-5676. Wang WQ, Wang WJ, Mathur MR, Youngblood YM, Jin JQ, Hou HY, Stasiak SL, Luan LY, Costello CJ, Yue YF. .
      View in: Publisher Site   Mentions:
    6. Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective. Cell. 2024 01 18; 187(2):446-463.e16. Mathur R, Wang Q, Schupp PG, Nikolic A, Hilz S, Hong C, Grishanina NR, Kwok D, Stevers NO, Jin Q, Youngblood MW, Stasiak LA, Hou Y, Wang J, Yamaguchi TN, Lafontaine M, Shai A, Smirnov IV, Solomon DA, Chang SM, Hervey-Jumper SL, Berger MS, Lupo JM, Okada H, Phillips JJ, Boutros PC, Gallo M, Oldham MC, Yue F, Costello JF. PMID: 38242087; PMCID: PMC10832360.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    7. GABP couples oncogene signaling to telomere regulation in TERT promoter mutant cancer. Cell Rep. 2022 09 20; 40(12):111344. McKinney AM, Mathur R, Stevers NO, Molinaro AM, Chang SM, Phillips JJ, Costello JF. PMID: 36130485; PMCID: PMC9534059.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    8. Abstract 3797: 3D whole tumor analysis of the TERT promoter mutation in gliomas. Cancer Research. 2022 Jun 15; 82(12_Supplement):3797-3797. Appin AC, Suwala SA, Hilz HS, Mathur MR, Smirnov SI, Hong HC, Stevers SN, Shai SA, Wang WA, Berger BM, Chang CS, Phillips PJ, Costello CJ. .
      View in: Publisher Site   Mentions:
    9. Abstract 3621: 3D spatial sampling and integrated omics reveal sources and patterning of intratumoral heterogeneity in glioblastoma. Cancer Research. 2022 Jun 15; 82(12_Supplement):3621-3621. Mathur MR, Wang WQ, Schupp SP, Nikolic NA, Yamaguchi YT, Hilz HS, Hong HC, Smirnov SI, LaFontaine LM, Phillips PJ, Chang CS, Li LY, Lupo LJ, Boutros BP, Gallo GM, Oldham OM, Yue YF, Costello CJ. .
      View in: Publisher Site   Mentions:
    10. PATH-28. RE-DEFINING CLONALITY OF THE TERT PROMOTER MUTATION WITH DEEP SEQUENCING AND MAXIMAL SAMPLING OF NEWLY DIAGNOSED AND RECURRENT GBM AND OLIGODENDROGLIOMA. Neuro-Oncology. 2021 Nov 12; 23(Supplement_6):vi121-vi121. Appin AC, Suwala SA, Hilz HS, Mathur MR, Smirnov SI, Hong HC, Stevers SN, Shai SA, Berger BM, Chang CS, Phillips PJ, Costello CJ. .
      View in: Publisher Site   Mentions:
    11. Epigenomic contributions to tumor cell heterogeneity and plasticity. Nat Genet. 2021 10; 53(10):1403-1404. Mathur R, Costello JF. PMID: 34608295.
      View in: PubMed   Mentions:    Fields:    
    12. ECOA-5. Integrative 3D spatial characterization of genomic and epigenomic intratumoral heterogeneity in glioblastoma. Neuro-Oncology Advances. 2021 Jul 5; 3(Supplement_2):ii2-ii2. Mathur MR, Wang WQ, Schupp SP, Hilz HS, Hong HC, Smirnov SI, Lafontaine LM, Nair ND, Iyyanaki IS, Phillips PJ, Chang CS, Li LY, Lupo LJ, Oldham OM, Yue YF, Costello CJ. .
      View in: Publisher Site   Mentions:
    13. MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence. Neuro Oncol. 2020 11 26; 22(11):1580-1590. Mathur R, Zhang Y, Grimmer MR, Hong C, Zhang M, Bollam S, Petrecca K, Clarke J, Berger MS, Phillips JJ, Oberheim-Bush NA, Molinaro AM, Chang SM, Costello JF. PMID: 32166314; PMCID: PMC8444710.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    14. EPCO-31. EPIGENOMIC INTRATUMORAL HETEROGENEITY OF GLIOBLASTOMA IN THREE-DIMENSIONAL SPACE. Neuro-Oncology. 2020 Nov 9; 22(Supplement_2):ii76-ii76. Mathur MR, Iyyanki IS, Hilz HS, Hong HC, Phillips PJ, Chang CS, Yue YF, Costello CJ. .
      View in: Publisher Site   Mentions:
    15. GENE-35. MGMT PROMOTER METHYLATION IN NEWLY DIAGNOSED LGG AS A POTENTIAL BIOMARKER FOR TMZ-ASSOCIATED HYPERMUTATION AT RECURRENCE. Neuro-Oncology. 2019 Nov 11; 21(Supplement_6):vi105-vi105. Mathur MR, Zhang ZY, Grimmer GM, Hong HC, Berger BM, Molinaro MA, Ann Oberheim-Bush AN, Chang CS, Costello CJ. .
      View in: Publisher Site   Mentions:
    16. ARID1A loss in cancer: Towards a mechanistic understanding. Pharmacol Ther. 2018 10; 190:15-23. Mathur R. PMID: 29730444.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansAnimals
    17. SWI/SNF (BAF) Complexes: Guardians of the Epigenome. Annual Review of Cancer Biology. 2018 Mar 4; 2(1):1-15. Mathur MR, Roberts RC. .
      View in: Publisher Site   Mentions:
    18. SWI/SNF (BAF) Complexes: Guardians of the Epigenome. Annual Review of Cancer Biology. 2017; 2:413-427. Radhika Mathur, Charles W. M. Roberts. View Publication.
    19. Abstract LB-286: ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice. Molecular and Cellular Biology, Genetics. 2017 Jul 1; lb-286-lb-286. Mathur MR, Alver AB, Roman RA, Wilson WB, Wang WX, Agoston AA, Park PP, Shivdasani SR, Roberts RC. .
      View in: Publisher Site   Mentions:
    20. ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice. Nat Genet. 2017 Feb; 49(2):296-302. Mathur R, Alver BH, San Roman AK, Wilson BG, Wang X, Agoston AT, Park PJ, Shivdasani RA, Roberts CW. PMID: 27941798; PMCID: PMC5285448.
      View in: PubMed   Mentions: 179     Fields:    Translation:HumansAnimalsCells
    21. Disruptive ARID1A Mutations in Follicular Lymphoma Impair DNA Repair Efficiency and Are Associated with Favorable Outcome in Patients Receiving First-Line Immunochemotherapy. Blood. 2015 Dec 3; 126(23):571. Bararia BD, Heide HM, Welner WR, Romashova RT, Pastore PA, Mathur MR, Gascoyne GR, Kridel KR, Willson WB, Roberts RC, Hiddemann HW, Weinstock WD, Weigert WO. .
      View in: Publisher Site   Mentions:
    22. Disruptive ARID1A Mutations in Follicular Lymphoma Impair DNA Repair Efficiency and Are Associated with Favorable Outcome in Patients Receiving First-Line Immunochemotherapy. Blood. 2015 Dec 3; 126(23):571. Bararia BD, Heide HM, Welner WR, Romashova RT, Pastore PA, Mathur MR, Gascoyne GR, Kridel KR, Willson WB, Roberts RC, Hiddemann HW, Weinstock WD, Weigert WO. .
      View in: Publisher Site   Mentions:
    Radhika's Networks
    Concepts (52)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (12)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-15-g9ae42700 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.